{"id":"W2792916595","doi":"10.1200/jco.2018.36.4_suppl.217","title":"A randomized phase 2 study of durvalumab monotherapy and in combination with tremelimumab in patients with metastatic pancreatic ductal adenocarcinoma (mPDAC): ALPS study.","year":2018,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Tremelimumab; Durvalumab; Internal medicine; Adverse effect; Clinical endpoint; Diarrhea; Gemcitabine; Gastroenterology; Randomized controlled trial; Combination therapy; Oncology; Population; Cancer; Ipilimumab; Immunotherapy; Nivolumab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002650846,0.001852406,0.002738946,0.0005957403,0.0004000343,0.001003174,0.001023485,0.001635841,0.005834703],"category_scores_gemma":[0.001604625,0.001019749,0.00192302,0.0004532719,0.001065139,0.001035531,0.0005416204,0.002606708,0.001143573],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009851303,"about_ca_system_score_gemma":0.001801239,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007542572,"about_ca_topic_score_gemma":0.001664878,"domain_scores_codex":[0.9990971,0.0005566503,0.00004195852,0.0001202287,0.0000628917,0.000121211],"domain_scores_gemma":[0.999017,0.000188246,0.0002058078,0.00008411409,0.00005408357,0.0004507405],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9628847,0.01654021,0.001694194,0.0002955407,0.0006572275,0.00008564693,0.00005527788,0.0003648953,0.004491635,0.00008130128,0.0008290302,0.01202026],"study_design_scores_gemma":[0.9105856,0.08616006,0.001749135,0.000008858097,0.0002630513,0.00004680047,0.0000122826,0.0002935274,0.0002922367,0.0000649331,0.000514198,0.000009322144],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9889206,0.001762819,0.0005881147,0.0005822488,0.0002456626,0.005081442,0.001365262,0.00009470694,0.001359145],"genre_scores_gemma":[0.9808583,0.00188289,0.002293121,0.001304312,0.0004398946,0.008163004,0.002136808,0.00003821504,0.002883522],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005834703,"threshold_uncertainty_score":0.01951903,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09852714321238622,"score_gpt":0.4710260784119542,"score_spread":0.372498935199568,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}